P005: Impact of Dose Reductions on Efficacy of Adjuvant Abemaciclib for Patients with High Risk Early Breast Cancer: Analyses from the monarchE Study

IF 5.7 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Breast Pub Date : 2025-02-01 DOI:10.1016/j.breast.2025.103899

V. Andre, J. O'Shaughnessy, I. Cicin, L. Testa, S. Tolaney, J. Huober, V. Guarneri, S. Johnston, M. Martin, P. Rastogi, N. Harbeck, H. Rugo, R. Wei, A. Shahir, M Goetz

引用次数: 0

查看原文本刊更多论文

P005：剂量减少对阿贝马昔lib辅助治疗高危早期乳腺癌疗效的影响：来自君主研究的分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast 医学-妇产科学

CiteScore

8.70

自引率

2.60%

发文量

165

审稿时长

59 days

期刊介绍： The Breast is an international, multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.